MBX 4291
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MBX 4291, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity [Phase 1]